N-acetylcysteine Plus Deferoxamine for Patients With Hypotension

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
Oxidative stress is associated with kidney damage in several different situations, including hypotension. In animal models it has been shown that the combination of n-acetylcysteine plus deferoxamine is superior to its isolate use in the treatment of several diseases. Thus the investigators aimed to determine if the administration of n-acetylcysteine plus deferoxamine could prevent renal failure in critical ill patients who develops hypotension.
Epistemonikos ID: c3f5b398ec3ed534fc3104696c857935699a3b5a
First added on: May 05, 2024